<DOC>
	<DOCNO>NCT01074242</DOCNO>
	<brief_summary>This survey conduct prepare application material re-examination Pharmaceutical Affairs Laws Enforcement Regulation , aim reconfirm clinical usefulness Rotateq collect safety information accord Re-examination Regulation New Drugs .</brief_summary>
	<brief_title>ROTATEQ Reexamination Study ( V260-037 )</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<criteria>Infants Who Are Vaccinated With Rotateq For The Prevention Of Rotavirus Gastroenteritis Within Local Labeling Will Be Included Participants vaccinate Rotateq study start Participant contraindication Rotateq accord local label</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>32 Weeks</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Gastroenteritis rotavirus</keyword>
</DOC>